NDC 47781-317

Nevirapine Extended Release

Nevirapine

Nevirapine Extended Release is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Alvogen Inc.. The primary component is Nevirapine.

Product ID47781-317_1587d234-f196-30ad-0ef2-9feeadc9bad4
NDC47781-317
Product TypeHuman Prescription Drug
Proprietary NameNevirapine Extended Release
Generic NameNevirapine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2015-07-14
Marketing CategoryANDA / ANDA
Application NumberANDA204621
Labeler NameAlvogen Inc.
Substance NameNEVIRAPINE
Active Ingredient Strength400 mg/1
Pharm ClassesHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [EXT],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 47781-317-30

30 TABLET in 1 BOTTLE (47781-317-30)
Marketing Start Date2015-07-14
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 47781-317-30 [47781031730]

Nevirapine Extended Release TABLET
Marketing CategoryANDA
Application NumberANDA204621
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-07-14

Drug Details

Active Ingredients

IngredientStrength
NEVIRAPINE400 mg/1

OpenFDA Data

SPL SET ID:af5e4797-ac41-98f3-64eb-d8def4a104fe
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1373745
  • 1095712

    • Pharmacological Class

    • Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Non-Nucleoside Analog [EXT]
    • Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
    • Cytochrome P450 3A Inducers [MoA]
    • Cytochrome P450 2B6 Inducers [MoA]

    Medicade Reported Pricing

    47781031730 NEVIRAPINE ER 400 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Nevirapine Extended Release" or generic name "Nevirapine"

    NDCBrand NameGeneric Name
    47781-317Nevirapine Extended Releasenevirapine
    0378-4050Nevirapinenevirapine
    0378-4890Nevirapinenevirapine
    0378-6950Nevirapinenevirapine
    0781-5893NevirapineNevirapine
    31722-505NevirapineNevirapine
    33342-004NevirapineNevirapine
    33342-238NEVIRAPINENEVIRAPINE
    42571-131NEVIRAPINENEVIRAPINE
    51991-331NevirapineNEVIRAPINE
    53104-0166nevirapinenevirapine
    53808-0680Nevirapinenevirapine
    53808-1069nevirapinenevirapine
    61442-470NevirapineNevirapine
    64380-709NevirapineNevirapine
    65162-209NevirapineNevirapine
    0597-0046Viramunenevirapine
    0597-0047Viramunenevirapine
    0597-0123Viramunenevirapine
    53808-0808Viramunenevirapine
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.